Jump To

Top Caption [Lead Opinion

                    by Panella](https://www.courtlistener.com/opinion/10805804/com-v-francis-c/about:blank#o1) [Concurrence


                    by Lazarus](https://www.courtlistener.com/opinion/10805804/com-v-francis-c/about:blank#o2)

Support FLP

CourtListener is a project of Free
Law Project, a federally-recognized 501(c)(3) non-profit. Members help support our work and get special access to features.

Please become a member today.

Join Free.law Now

March 9, 2026 Get Citation Alerts Download PDF Add Note

Com. v. Francis, C.

Superior Court of Pennsylvania

• Citations: None known
• Docket Number: 1086 EDA 2025
• Precedential Status: Non-Precedential
• Panel: Anne E. Lazarus, Jack A. Panella

• Judges: Panella; Lazarus

• Opinion

• Authorities (10)

• Cited By (0)

• Summaries (0)

• Similar Cases (10.2K)

• PDF

Lead Opinion

                        by [Jack A. Panella](https://www.courtlistener.com/person/8243/jack-a-panella/)

J-A30030-25

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT O.P. 65.37

COMMONWEALTH OF PENNSYLVANIA : IN THE SUPERIOR COURT OF
: PENNSYLVANIA
Appellant :
:
:
v. :
:
:
CAESAR CHEVAR FRANCIS : No. 1086 EDA 2025

Appeal from the Order Entered April 10, 2025
In the Court of Common Pleas of Pike County
Criminal Division at No(s): CP-52-CR-0000615-2023

BEFORE: LAZARUS, P.J., PANELLA, P.J.E., and SULLIVAN, J.

MEMORANDUM BY PANELLA, P.J.E.: FILED MARCH 9, 2026

The Commonwealth appeals from the trial court’s April 10, 2025 pretrial

order denying the Commonwealth’s motion in limine seeking to admit

testimony of the forensic scientist who authored the lab report that found

delta-9-tetrahydrocannabinol (“THC”) and delta-8-THC in the vape pen

devices recovered near Caesar Chevar Francis during a traffic stop. The

Commonwealth argues that the trial court abused its discretion by failing to

provide any legal basis for precluding the relevant expert testimony. We agree

with the Commonwealth because the preceding order precluding admission of

the lab report did not necessarily preclude the testimony of the forensic

scientist; and, based on our review of the entire certified record, there is no

other basis for precluding that relevant testimony. Thus, we reverse and

remand.
J-A30030-25

We glean the following facts from the affidavit of probable cause in the

criminal complaint. On June 13, 2023, around 6:30 a.m., a Pennsylvania State

Police trooper initiated a traffic stop on Interstate 84 in Greene Township, Pike

County, based on his observations of a vehicle with a visible crack in its

windshield, improperly engaging its left turn signal, and swerving within its

lane. The driver, Francis, was the sole occupant. Upon interacting with Francis,

the trooper observed indicia of intoxication—bloodshot, glassy eyes,

constricted pupils, and slow, choppy speech. Further, the trooper saw what he

identified as a THC vape pen in the center console. Francis told the trooper

that he did not have a medical marijuana card and that the vape pen was old.

The trooper observed that the vape pen was full and new.

Francis complied with the trooper’s request to perform sobriety tests.

Based on Francis’s performance and the trooper’s earlier observations, the

trooper concluded that Francis was impaired. Francis was handcuffed and

placed in the patrol vehicle. The trooper read Francis the DL-26 form 1 and

Francis refused to submit to a chemical blood test.

Based on these allegations, Francis was charged with DUI (75 Pa.C.S.A.

§ 3802(d)(2)); Possession of a Controlled Substance (35 P.S. § 780-

---

1 The DL-26 form advises an arrestee suspected of driving under the influence

(“DUI”) of enhanced criminal penalties for refusing to submit to a chemical
blood test pursuant to Pennsylvania’s Implied Consent Law, 75 Pa.C.S.A. §
1547. See Commonwealth v. Gaston, 239 A.3d 135, 137 n.4 (Pa. Super.
2020).

-2-
J-A30030-25

113(a)(16)); Possession of Drug Paraphernalia (35 P.S. § 780-113(a)(32));

Windshield Obstruction (75 Pa.C.S.A. § 4524(e)(1)); Safety Glass (75

Pa.C.S.A. § 4526(a)); and Careless Driving (75 Pa.C.S.A. § 3714(a)).

After numerous defense continuances, the parties appeared for the call

of the list on October 28, 2024, and upon their representation that they were

prepared for trial, trial was scheduled for the November trial term. On

November 4, 2024, the day before the deadline for filing pretrial motions,

Francis filed a motion seeking to dismiss the drug possession and

paraphernalia charges for lack of chemical testing to establish the substance

in the vape pens.2 On November 12, 2024, the date set for jury selection, the

trial again was continued, seemingly because the Commonwealth had not yet

received the lab test results.3

On December 30, 2024, the Commonwealth filed a petition for a non-

jury trial and an amended information removing the drug possession and

paraphernalia charges. The following day the lab report, which was dated

December 18, 2024, was provided to the defense. The lab report stated that

---

2 The criminal complaint states that one vape pen was found in Francis’s center

console. It appears that a second vape pen belonging to Francis was
discovered at some point.

3 The Commonwealth does not appear to dispute Francis’s contention that trial

was continued upon the Commonwealth’s request because the Commonwealth
had not yet received the lab test results. See Motion to Preclude Lab Reports,
1/7/25, at ¶¶ 9-10. However, the continuance order indicates that the trial
was continued upon the defense’s request. See Continuance Application,
11/12/24, at § 5.

-3-
J-A30030-25

one of the vape pens contained delta-9-THC and delta-8-THC, and the other

one contained delta-9-THC.

On January 7, 2025, Francis filed a motion seeking to preclude the

Commonwealth from introducing the lab report at trial because the

Commonwealth failed to exercise due diligence in submitting the vape pens

for testing.

On January 29, 2025, oral argument was held, and the trial court took

the matter under advisement. At argument, defense counsel sought to make

an oral motion to amend its motion to also preclude any mention of the vape

pens. See N.T., 1/29/25, at 4-5, 9-10.

Notably, the trial court denied the oral motion and limited its

consideration to only the preclusion of the lab report. See id.; Order, 1/29/25.

On February 3, 2025, the Commonwealth filed a response and

supplement to the record that indicated that, contrary to Francis’s assertion,

it did not wait to submit the vape pens for testing until after Francis filed his

motion to dismiss on November 4, 2024. Instead, it sent the state police an

email request for the vape pens to be tested on October 28, 2024, after the

defense indicated at call of the list that the case would proceed to trial, but

the lab did not receive the vape pens until November 8, 2024. On February 4,

2025, the trial court issued an order granting Francis’s motion to preclude the

lab report but did not offer any explanation for its ruling. See Order, 2/4/25.

-4-
J-A30030-25

On February 7, 2025, the Commonwealth filed a motion in limine

seeking to admit the testimony of the forensic scientist who authored the

precluded lab report. Oral argument was held on April 10, 2025. Later that

same day the trial court issued an order denying the Commonwealth’s motion

and stated, “[c]onsistent with our February 4, 202[5] Order, expert testimony

regarding the report and the findings contained therein shall not be permitted

at trial.” Order, 4/10/25.

The Commonwealth appealed pursuant to Pa.R.A.P. 311(d) and certified

that the April 10, 2025 order will terminate or substantially handicap the

prosecution. Pursuant to the trial court’s order, the Commonwealth filed a

timely statement of errors complained of on appeal, and the trial court issued

a two-page Rule 1925(a) opinion in support of its ruling. See Pa.R.A.P.

1925(a), (b). The trial court stated that the Commonwealth’s appeal is “an

improper attempt to circumvent [the] February 4, 2025 Order.” Trial Court

Opinion, 6/13/25, at 2. Further, the trial court explained

While Pa. R.Crim.P. 574 allows for the use of a forensic laboratory
report in lieu of expert testimony at trial if a defendant does not
make a timely demand, the reverse is not contemplated. We do
not believe that the Commonwealth should be permitted to call an
expert witness in lieu of a lab report where the report has already
been specifically excluded. There is no rule which allows the
Commonwealth to bypass the production of an expert report prior
to calling an expert witness.

-5-
J-A30030-25

Id.4

The Commonwealth raises a single issue for our review.

Whether the trial court erred in excluding the testimony of a
forensic scientist to identify the substance contained in a vape
device found in the vehicle?

Appellant’s Brief, at 4 (unnecessary capitalization omitted).

“[W]hen reviewing the denial of a motion in limine, we apply an

evidentiary abuse of discretion standard of review[]” because “[t]he admission

of evidence is committed to the sound discretion of the trial court[.]”

Commonwealth v. Sami, 243 A.3d 991, 997 (Pa. Super. 2020) (citation

omitted). “The trial court abuses its discretion only if it misapplies the law, or

its exercise of judgment is manifestly unreasonable or the result of partiality,

prejudice, bias or ill-will.” Commonwealth v. Nabried, 327 A.3d 315, 321

(Pa. Super. 2024) (citation omitted).

The Commonwealth argues that the trial court erred in precluding the

expert testimony because the testimony is relevant and the trial court failed

to provide a reason for its decision. See Appellant’s Brief, at 15-17. The trial

court states, and Francis argues, that the preclusion of the lab report

---

4 Additionally, in its 1925(a) opinion the trial court states that we lack
jurisdiction because precluding the expert testimony does not substantially
handicap or terminate the Commonwealth’s case. See Trial Court Opinion,
6/13/25, at 1-2. “[W]hen a pretrial order has the effect of excluding
Commonwealth evidence, this Court is not permitted to inquire into the
Commonwealth’s good-faith certification.” Commonwealth v. McKnight,
305 A.3d 582, 586 (Pa. Super. 2023), appeal denied, 327 A.3d 184 (Pa. 2024)
(citation and internal quotation marks omitted).

-6-
J-A30030-25

necessarily precluded the testimony of the forensic scientist who authored the

report. See Trial Court Opinion, 6/13/25, at 2; Appellee’s Brief, at 10 (“logic

dictates that the preclusion of the lab report necessarily included preclusion

of the testimony of the expert.”). Alternatively, Francis argues that the trial

court acted within its discretion by precluding the expert testimony based on

the Commonwealth’s failure to abide by discovery rules. See Appellee’s Brief,

at 12 (citing Pa.R.Crim.P. 573(E)). Further, Francis argues that allowing such

expert testimony would permit the Commonwealth to engage in “trial by

ambush” by not producing an expert report and just calling the expert at trial.

See id. at 10-11.

At the outset, a few preliminary observations help to focus our analysis.

First, our review does not concern the trial court’s February 4, 2025 order

precluding the lab report. As such, the preclusion of the lab report is accepted

as part of the record. Second, the February 4, 2025 order clearly only

precluded the lab report. Thus, that order did not explicitly preclude the author

of the report from testifying. Third, the expert testimony regarding the

chemical composition of the vape pens is clearly relevant. See

Commonwealth v. Cahill, 324 A.3d 516, 527 (Pa. Super. 2024) (finding the

presence of marijuana in a vehicle helped establish sufficient evidence of guilt

under 75 Pa.C.S.A. § 3802(d)(2)); see also Appellee’s Brief, at 12 (conceding

that the expert testimony could be relevant).

-7-
J-A30030-25

We have found no cases, and neither the trial court nor Francis have

cited any, that hold that a forensic scientist who authored a lab report testing

for drugs is precluded from testifying because the lab report is precluded.

“Courts in Pennsylvania have long held that opinions based on inadmissible

evidence . . . are admissible.” Brown v. Halpern, 202 A.3d 687, 707 (Pa.

Super. 2019) (citing Commonwealth v. Brown, 139 A.3d 208, 218 (Pa.

Super. 2016), affirmed, 185 A.3d 316 (Pa. 2018)). Under the Pennsylvania

Rules of Evidence:

An expert may base an opinion on facts or data in the case that
the expert has been made aware of or personally observed. If
experts in the particular field would reasonably rely on those kinds
of facts or data in forming an opinion on the subject, they need
not be admissible for the opinion to be admitted.

Pa.R.E. 703.

When an expert testifies about the underlying facts and data that
support the expert’s opinion and the evidence would be otherwise
inadmissible, the trial judge upon request must, or on the judge’s
own initiative may, instruct the jury to consider the facts and data
only to explain the basis for the expert’s opinion, and not as
substantive evidence.

Pa.R.E. 705, cmt.

Based on the foregoing rules of evidence we see no reason why the

Commonwealth’s forensic scientist could not testify to her own personal

observations, methodology, and underlying data regarding the chemical

testing of the vape pens. Therefore, we are constrained to conclude that the

trial court erred in relying on the preclusion of the expert report as a sufficient

reason for completely precluding the expert testimony.

-8-
J-A30030-25

Moreover, we are not persuaded by Francis’s alternative argument that

the trial court properly exercised its discretion in precluding the evidence as a

sanction for the Commonwealth’s violation of Rule 573, an argument he is

making here for the first time. See Appellee’s Brief, at 12; N.T., 4/10/25, at

4-6 (defense counsel arguing the court should preclude the expert testimony

because the court already precluded the lab report, not because of a Rule 573

discovery violation); Pa.R.Crim.P. 573(E).5

Of course, “we may affirm the trial court’s ruling on any basis supported

by the record.” Commonwealth v. Wade, 226 A.3d 1023, 1031 (Pa. Super.

2020) (citation omitted). However, we generally do not affirm the trial court

on alternative grounds that require the exercise of discretion. See In re

A.J.R.-H., 188 A.3d 1157, 1176 (Pa. 2018) (“The [“right for any reason”]

doctrine thus may be applied by a reviewing court if the established facts

support a legal conclusion producing the same outcome. It may not be used

to affirm a decision when the appellate court must weigh evidence and engage

in fact finding or make credibility determinations to reach a legal conclusion.”).

---

5 The Commonwealth was the only party to briefly mention Rule 573. In its

response/supplement to the record in opposition to Francis’s motion to
preclude the lab report, the Commonwealth stated “[Francis] has failed to
show why he has been or would have been prejudiced in any way, had the
Commonwealth not sent out the item[s] for laboratory testing. To date there
has been no allegation that there was a discovery violation under Rule 573 of
the Rules of Criminal Procedure[.]” Commonwealth’s Response/Supplement
to the Record, 2/3/25, at 2.

-9-
J-A30030-25

It is well-settled that, under Rule 573(E), “[t]he trial court has broad

discretion in choosing the appropriate remedy for a discovery violation.”

Commonwealth v. Brown, 200 A.3d 986, 993 (Pa. Super. 2018) (citation

omitted). The court “may order [a violating] party to permit discovery or

inspection, may grant a continuance, or may prohibit such party from

introducing evidence not disclosed, . . . or it may enter such other order as it

deems just under the circumstances.” Pa.R.Crim.P. 573(E). Further, “[a]

defendant seeking relief from a discovery violation must demonstrate

prejudice.” Brown, 200 A.3d at 993 (citation omitted).

Here, the trial court never stated that it was precluding the testimony

because of a discovery violation under Rule 573(E) or that it had considered

Rule 573(E) at all, as this argument was not presented for the trial court’s

consideration. See Order, 2/4/25; Order, 4/10/25; Trial Court Opinion,

6/13/25, at 2. Therefore, we decline to affirm on that alternative basis. The

applicability of a sanction pursuant to Rule 573(E) would have required the

trial court to exercise its discretion by both considering any prejudice to

Francis, which the record reveals he failed to show, and the appropriate

sanction to be imposed. See N.T., 4/10/25, at 4-6; Brown, 200 A.3d at 993;

Pa.R.Crim.P. 573(E). We will not exercise such discretion on its behalf. 6

---

6 We also note that we do not share Francis’s concern that allowing the forensic

scientist in this case to testify would permit trial by ambush. See Appellee’s
Brief, at 11. Nothing in our ruling approves of “trial by ambush” by obviating
(Footnote Continued Next Page)

• 10 - J-A30030-25

In sum, we are constrained to conclude the trial court erred in finding

that precluding the lab report ipso facto precluded the testimony of the

forensic scientist who authored the lab report, as she still would be able to

testify to “the underlying facts and data that support [her] opinion,” with an

appropriate limiting instruction from the court either on its own initiative or at

the request of a party. Pa.R.E. 705, cmt. Further, we decline Francis’s

invitation to exercise our discretion on the trial court’s behalf to affirm on the

alternative basis of Rule 573(E). Therefore, the trial court’s April 10, 2025

order is reversed and the matter is remanded for proceedings consistent with

this memorandum.

Order reversed. Case remanded for further proceedings. Jurisdiction

relinquished.

President Judge Lazarus files a concurring statement.

Judge Sullivan notes dissent.

---

the Commonwealth’s need to abide by discovery rules or the trial court’s
authority to fashion appropriate remedies for discovery violations. Instead,
our ruling is relatively narrow based on the specific facts and procedural
posture of this case. That is, when neither the opposing party nor the trial
court raise Rule 573(E) as grounds for precluding evidence, we will not invoke
Rule 573(E) to affirm the trial court.

• 11 - J-A30030-25

Date: 3/9/2026

• 12 -

  Concurrence Opinion

                      by [Anne E. Lazarus](https://www.courtlistener.com/person/8236/anne-e-lazarus/)
  

J-A30030-25

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT O.P. 65.37

COMMONWEALTH OF PENNSYLVANIA : IN THE SUPERIOR COURT OF
: PENNSYLVANIA
Appellant :
:
:
v. :
:
:
CAESAR CHEVAR FRANCIS : No. 1086 EDA 2025

Appeal from the Order Entered April 10, 2025
In the Court of Common Pleas of Pike County Criminal Division at No(s):
CP-52-CR-0000615-2023

BEFORE: LAZARUS, P.J., PANELLA, P.J.E., and SULLIVAN, J.

CONCURRING STATEMENT LAZARUS, P.J.: FILED MARCH 9, 2026

I join the learned majority in full, but write separately to express my

displeasure with the state of this record. Based upon my review, I believe

that the trial court excluded the expert report, and presumably the expert

testimony in its April 10, 2025 order, due to a potential discovery violation by

the Commonwealth’s failure to timely request drug testing of the vape pens

found in Francis’s vehicle. See Pa.R.Crim.P. 573. However, neither Francis’s

motion in limine nor the trial court’s orders make any mention of a discovery

violation. Further, there is no ruling about what potential discovery rule the

Commonwealth violated and the trial court did not address the potential

remedies that are set forth under Rule 573(E). This Court is not permitted

to speculate as to the basis of a trial court’s ruling and we are limited to only

the record before us. Therefore, I am constrained to join the majority’s

disposition.
J-A30030-25

Panella, P.J.E., Joins Concurring Statement

Sullivan, J., Notes Her Dissent

-2-